Suspecting that a particular protein in tuberculosis was likely to be vital to the bacteria's survival, scientists screened 175,000 small chemical compounds and identified a potent class of compounds that selectively slows down this protein's activity and, in a test tube, blocks TB growth, demonstrating that the protein is indeed a vulnerable target.